Structural Insights and Functional Impact of the MmpL3 Inhibitor C215
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F24%3A10497228" target="_blank" >RIV/00216208:11160/24:10497228 - isvavai.cz</a>
Result on the web
<a href="http://www.ccsss.cz/index.php/ccsss/issue/view/48" target="_blank" >http://www.ccsss.cz/index.php/ccsss/issue/view/48</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Structural Insights and Functional Impact of the MmpL3 Inhibitor C215
Original language description
Tuberculosis TB is a globally prevalent infectious disease caused by Mycobacterium tuberculosis (Mtb). We developed a straightforward synthesis of C215 and its derivatives and established a basic pharmacological profile.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
<a href="/en/project/LX22NPO5103" target="_blank" >LX22NPO5103: National Institute of Virology and Bacteriology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů